Genetics and Pathogenesis of Inflammatory Bowel Disease

Annual Review of Pathology: Mechanisms of Disease

Volumn 11, Issue , 2016, Pages 127-148

  Liu, Ta Chiang ^a   Stappenbeck, Thaddeus S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Causative variants; Crohn's disease; Genome wide association study; Ulcerative colitis

Indexed keywords

INTERLEUKIN 10 RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALLELE; ARTICLE; ENVIRONMENTAL FACTOR; GENE; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; HUMAN; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; MICROBIOME; MOUSE MODEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; XIAP GENE; ANIMAL; GENETICS; PATHOLOGY;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84971251096     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-012615-044152     Document Type: Article

References (121)

1. Baumgart DC, SandbornWJ. 2012. Crohn's disease. Lancet 380:1590-605
2. Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. 2012. Ulcerative colitis. Lancet 380:1606-19
3. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119-24
4. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. 2011. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43:246-52
5. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. 2011. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 43:1066-73
6. EllinghausD, Zhang H, Zeissig S, Lipinski S,Till A, et al. 2013. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology 145:339-47
7. Christodoulou K, Wiskin AE, Gibson J, Tapper W, Willis C, et al. 2013. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut 62:977-84
8. Khor B, Gardet A, Xavier RJ. 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307-17
9. Graham DB,XavierRJ. 2013. From genetics of inflammatory bowel disease towards mechanistic insights. Trends Immunol. 34:371-78
10. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, et al. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9:356-69
11. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. 2009. Finding the missing heritability of complex diseases. Nature 461:747-53
12. Cho JH, Brant SR. 2011. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140:1704-12
13. Lee S, Abecasis GR, Boehnke M, Lin X. 2014. Rare-variant association analysis: study designs and statistical tests. Am. J. Hum. Genet. 95:5-23
14. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-63
15. Orange JS,Glessner JT,Resnick E, Sullivan KE,LucasM,et al. 2011. Genome-wide association identifies diverse causes of common variable immunodeficiency. J. Allergy Clin. Immunol. 127:1360-67.e6
16. Stray-Pedersen A, Backe PH, Sorte HS, Morkrid L, Chokshi NY, et al. 2014. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am. J. Hum. Genet. 95:96-107
17. Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, et al. 2014. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 147:990-1007.e3
18. Muise AM, Walters T, Xu W, Shen-Tu G, Guo CH, et al. 2011. Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. Gastroenterology 141:633-41
19. Muise AM, Xu W, Guo CH, Walters TD, Wolters VM, et al. 2012. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 61:1028-35
20. Dhillon SS, Fattouh R, Elkadri A, Xu W, Murchie R, et al. 2014. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology 147:680-89.e2
21. LeoniG,Alam A, Neumann PA, Lambeth JD, ChengG, et al. 2013. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J. Clin. Investig. 123:443-54
22. LeoniG,Neumann PA, Kamaly N, Quiros M, Nishio H, et al. 2015. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J. Clin. Investig. 125(3):1215-27
23. Avitzur Y, Guo C, Mastropaolo LA, Bahrami E, Chen H, et al. 2014. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 146:1028-39
24. Bigorgne AE, Farin HF, Lemoine R, Mahlaoui N, Lambert N, et al. 2014. TTC7A mutations disrupt intestinal epithelial apicobasal polarity. J. Clin. Investig. 124:328-37
25. Zeissig Y, Petersen BS, Milutinovic S, Bosse E, Mayr G, et al. 2015. XIAP variants in male Crohn's disease. Gut 64:66-76
26. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, et al. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361:2033-45
27. KotlarzD, Beier R, MuruganD,Diestelhorst J, JensenO, et al. 2012. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 143:347-55
28. Olszak T, Neves JF,DowdsCM,Baker K, Glickman J, et al. 2014. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 509:497-502
29. Shouval DS, Biswas A,Goettel JA, McCann K, Conaway E, et al. 2014. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 40:706-19
30. Zigmond E, Bernshtein B, Friedlander G, Walker CR, Yona S, et al. 2014. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40:720-33
31. MacDuff DA, Reese TA, Kimmey JM, Weiss LA, Song C, et al. 2015. Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection. eLife 4:e04494
32. Carmi S, Hui KY, Kochav E, Liu X, Xue J, et al. 2014. Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nat. Commun. 5:4835
33. Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, et al. 2012. A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLOS Genet. 8:e1002559
34. Zhang W, Hui KY, Gusev A, Warner N, Ng SM, et al. 2013. Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3. Genes Immun. 14:310-16
35. Yang SK, Hong M, Zhao W, Jung Y, Baek J, et al. 2014. Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut 63:80-87
36. YamazakiK, Umeno J, TakahashiA,HiranoA, Johnson TA, et al. 2013.Agenome-wide association study identifies 2 susceptibility loci for Crohn's disease in a Japanese population. Gastroenterology 144:781-88
37. Hirano A, Yamazaki K, Umeno J, Ashikawa K, Aoki M, et al. 2013. Association study of 71 European Crohn's disease susceptibility loci in a Japanese population. Inflamm. Bowel Dis. 19:526-33
38. Hong SN, Park C, Park SJ, Lee CK, Ye BD, et al. 2015. Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants. Gut 65:788-96
39. Yang SK,HongM, ZhaoW, Jung Y, TayebiN, et al. 2013. Genome-wide association study of ulcerative colitis in Koreans suggests extensive overlapping of genetic susceptibilitywith Caucasians. Inflamm. Bowel Dis. 19:954-66
40. Ananthakrishnan AN, Huang H, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. 2014. Differential effect of genetic burden on disease phenotypes in Crohn's disease and ulcerative colitis: analysis of a North American cohort. Am. J. Gastroenterol. 109:395-400
41. Polychronakos C, Li Q. 2011. Understanding type 1 diabetes through genetics: advances and prospects. Nat. Rev. Genet. 12:781-92
42. Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, et al. 2014. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518:337-43
43. Parkes M, Cortes A, van Heel DA, Brown MA. 2013. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14:661-73
44. Yang SK, Hong M, Choi H, Zhao W, Jung Y, et al. 2014. Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans. Inflamm. Bowel Dis. 21:1-7
45. Cortes A, Brown MA. 2011. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13:101
46. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, et al. 2011. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43:1193-201
47. Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, et al. 2015. High-density mapping of the MHC identifies a shared role for HLA-DRB1∗01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 47:172-79
48. Vahedi G, Kanno Y, Furumoto Y, Jiang K, Parker SC, et al. 2015. Super-enhancers delineate diseaseassociated regulatory nodes in T cells. Nature 520:558-62
49. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, et al. 2013. Super-enhancers in the control of cell identity and disease. Cell 155:934-47
50. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med. 345:1098-104
51. SandbornWJ, Gasink C, Gao LL, Blank MA, Johanns J, et al. 2012. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N. Engl. J. Med. 367:1519-28
52. Sokol H, Conway KL, ZhangM, ChoiM,Morin B, et al. 2013. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 145:591-601.e3
53. Vang T, Congia M, Macis MD, Musumeci L, Orru V, et al. 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37:1317-19
54. Diaz-Gallo LM, Espino-Paisan L, Fransen K, Gomez-Garcia M, van Sommeren S, et al. 2011. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 17:2287-94
55. Rhee I, Veillette A. 2012. Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat. Immunol. 13:439-47
56. Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. 2014. NOD proteins: regulators of inflammation in health and disease. Nat. Rev. Immunol. 14:9-23
57. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M. 2009. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10:184-94
58. Morley M, Molony CM,Weber TM,Devlin JL, EwensKG, et al. 2004. Genetic analysis of genome-wide variation in human gene expression. Nature 430:743-47
59. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. 2007. A genome-wide association study of global gene expression. Nat. Genet. 39:1202-7
60. Fairfax BP, Humburg P,Makino S,Naranbhai V,WongD, et al. 2014. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343:1246949
61. Wang MH, Fiocchi C, Zhu X, Ripke S, Kamboh MI, et al. 2014. Gene-gene and gene-environment interactions in ulcerative colitis. Hum. Genet. 133:547-58
62. Wagner J, Sim WH, Ellis JA, Ong EK, Catto-Smith AG, et al. 2010. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PLOS ONE 5:e15376
63. Hedl M, Lahiri A, Ning K, Cho JH, Abraham C. 2014. Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn's disease ICOSLG risk allele. Immunity 40:734-46
64. Adolph TE, Tomczak MF, Niederreiter L, Ko HJ, Bock J, et al. 2013. Paneth cells as a site of origin for intestinal inflammation. Nature 503:272-76
65. Rogler G, Vavricka S. 2014. Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm. Bowel Dis. 21:400-8
66. Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV Jr, et al. 2013. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 62:630-49
67. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, et al. 2011. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9:390-403
68. Ng SC, Tang W, Leong RW, Chen M, Ko Y, et al. 2014. Environmental risk factors in inflammatory bowel disease: A population-based case-control study in Asia-Pacific. Gut 64:1063-71
69. Ananthakrishnan AN, Nguyen DD, Sauk J, YajnikV, Xavier RJ. 2014. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm. Bowel Dis. 20:783-89
70. Verschuere S, De Smet R, Allais L, CuvelierCA. 2012. The effect of smoking on intestinal inflammation: What can be learned from animal models? J. Crohn's Colitis 6:1-12
71. Ueno A, Jijon H, Traves S, Chan R, Ford K, et al. 2014. Opposing effects of smoking in ulcerative colitis and Crohn's disease may be explained by differential effects on dendritic cells. Inflamm. Bowel Dis. 20:800-10
72. Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, et al. 2015. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 148:1087-106
73. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, et al. 2015. Genetic studies of body mass index yield new insights for obesity biology. Nature 518:197-206
74. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, et al. 2015. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518:187-96
75. Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, et al. 2015. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519:92-96
76. Martinez-MedinaM,Denizot J,Dreux N, Robin F, Billard E, et al. 2014. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 63:116-24
77. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, et al. 2012. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487:104-8
78. Greenblum S, Turnbaugh PJ, Borenstein E. 2012. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. PNAS 109:594-99
79. Hunter DJ. 2005. Gene-environment interactions in human diseases. Nat. Rev. Genet. 6:287-98
80. KhouryMJ, AdamsMJ Jr, Flanders WD. 1988. An epidemiologic approach to ecogenetics. Am. J. Hum. Genet. 42:89-95
81. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, et al. 2013. The Oslo definitions for coeliac disease and related terms. Gut 62:43-52
82. Khoury MJ, Flanders WD. 1996. Nontraditional epidemiologic approaches in the analysis of geneenvironment interaction: case-control studies with no controls! Am. J. Epidemiol. 144:207-13
83. Smith PG, Day NE. 1984. The design of case-control studies: The influence of confounding and interaction effects. Int. J. Epidemiol. 13:356-65
84. Belkaid Y, Hand TW. 2014. Role of the microbiota in immunity and inflammation. Cell 157:121-41
85. Goodrich JK, Di Rienzi SC, Poole AC, Koren O, Walters WA, et al. 2014. Conducting a microbiome study. Cell 158:250-62
86. Kostic AD, Xavier RJ, Gevers D. 2014. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146:1489-99
87. Knights D, Lassen KG, Xavier RJ. 2013. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 62:1505-10
88. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, et al. 2010. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139:1844-54.e1
89. JoossensM,Huys G, CnockaertM,DePreterV,Verbeke K, et al. 2011. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60:631-37
90. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, et al. 2014. The treatmentnaive microbiome in new-onset Crohn's disease. Cell Host Microbe 15:382-92
91. Sadaghian SadabadM, Regeling A, deGoffauMC, Blokzijl T,Weersma RK, et al. 2015. The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients. Gut 64:1546-52
92. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, et al. 2014. Human genetics shape the gut microbiome. Cell 159:789-99
93. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, et al. 2014. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63:1275-83
94. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, et al. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569-73
95. Virgin HW, Todd JA. 2011. Metagenomics and personalized medicine. Cell 147:44-56
96. Olszak T, An D, Zeissig S, Vera MP, Richter J, et al. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489-93
97. Moon C, Baldridge MT, Wallace MA, Burnham CA, Virgin HW, Stappenbeck TS. 2015. Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation. Nature 521:90-93
98. Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, et al. 2015. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160:447-60
99. Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, et al. 2014. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158:1000-10
100. Lassen KG, Kuballa P, Conway KL, Patel KK, Becker CE, et al. 2014. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. PNAS 111:7741-46
101. Murthy A, Li Y, Peng I, Reichelt M, Katakam AK, et al. 2014. A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3. Nature 506:456-62
102. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, et al. 2010. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141:1135-45
103. Cadwell K, Liu JY, Brown SL, MiyoshiH, Loh J, et al. 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259-63
104. VanDussenKL, LiuTC, Li D, Towfic F,ModianoN, et al. 2014. Genetic variants synthesize to produce Paneth cell phenotypes that define subtypes of Crohn's disease. Gastroenterology 146:200-9
105. Marchiando AM, Ramanan D, Ding Y, Gomez LE, Hubbard-Lucey VM, et al. 2013. A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. Cell Host Microbe 14:216-24
106. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, et al. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145:745-57
107. Conway KL,Kuballa P, Song JH, Patel KK, Castoreno AB, et al. 2013. Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology 145:1347-57
108. Pelletier S, Gingras S, Green DR. 2015. Mouse genome engineering via CRISPR-Cas9 for study of immune function. Immunity 42:18-27
109. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, et al. 2005. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128:891-906
110. Liu B, Tonkonogy SL, Sartor RB. 2011. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology 141:653-62, 662.e1-4
111. Im E, Jung J, Pothoulakis C, Rhee SH. 2014. Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10-/- mice. Gastroenterology 147:667-79.e10
112. VanDussenKL, Marinshaw JM, ShaikhN,Miyoshi H, Moon C, et al. 2015. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64:911-20
113. van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, et al. 2015. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:933-45
114. Plevy S, Silverberg MS, Lockton S, Stockfisch T, Croner L, et al. 2013. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients. Inflamm. Bowel Dis. 19:1139-48
115. van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, et al. 2013. Serological markers predict inflammatory bowel disease years before the diagnosis. Gut 62:683-88
116. Cleynen I, Gonzalez JR, Figueroa C, Franke A, McGovern D, et al. 2013. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut 62:1556-65
117. Alonso A, Domenech E, Julia A, Panes J, Garcia-Sanchez V, et al. 2015. Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study. Gastroenterology 148:794-805
118. Haritunians T, Taylor KD, Targan SR, Dubinsky M, Ippoliti A, et al. 2010. Genetic predictors of medically refractory ulcerative colitis. Inflamm. Bowel Dis. 16:1830-40
119. Ryan JD, Silverberg MS, XuW, Graff LA, Targownik LE, et al. 2013. Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a populationbased cohort. Aliment. Pharmacol. Ther. 38:274-83
120. Yang SK, Hong M, Baek J, Choi H, Zhao W, et al. 2014. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat. Genet. 46:1017-20
121. Stessman HA, Bernier R, Eichler EE. 2014. A genotype-first approach to defining the subtypes of a complex disease. Cell 156:872-77